Given that administration of AngII and BAPN is often used to generate the animal AAA model47,48, the utilization of these reagents could be acceptable for the investigation of function of the target molecule, such as RhoA, in the process and mechanism of AAA formation. The gene discussed is AGT; the disease is triple-A syndrome.